Company / Free Cash Flow per Share
Corbus Pharmaceuticals Holdings, Inc. Free Cash Flow per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$11.57
FY2022
5-year range
-$11.57 / -$0.51
FY2018-FY2022
Trend
-1041.7%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -1042% YoY in FY2022, a notable deviation from the 7-year average annual change of -209%.
Based on SEC 10-K filings.
-11.57 in FY2022.
Declined from $-0.75 to $-11.57 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Corbus Pharmaceuticals Holdings, Inc.'s free cash flow per share has declined for 5 consecutive years.
- In FY2022, free cash flow per share decreased 1041.7% year-over-year.
- Peak free cash flow per share was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$11.57 | -1041.7% |
| FY2021 | -$1.01 | -35.2% |
| FY2020 | -$0.75 | -32.5% |
| FY2019 | -$0.57 | -10.3% |
| FY2018 | -$0.51 | -306.8% |
| FY2017 | -$0.13 | +0.0% |
| FY2016 | -$0.13 | -34.8% |
| FY2015 | -$0.09 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026